NSAIDs Should Generally Be Avoided with Lithium, Even at Low Doses
NSAIDs significantly increase lithium serum levels and should be avoided in patients taking lithium, regardless of the lithium dose, due to the substantial risk of lithium toxicity. The FDA drug label explicitly warns that "lithium toxicity has resulted from interactions between an NSAID and lithium" 1.
The Mechanism and Magnitude of Risk
NSAIDs reduce renal lithium clearance by affecting prostaglandin-mediated renal blood flow, leading to elevated lithium levels. The FDA label states that NSAIDs can increase steady-state lithium plasma levels by approximately 17% (as demonstrated with celecoxib), though increases up to 99% with celecoxib and 448% with rofecoxib have been reported 1, 2. Indomethacin appears most potent, decreasing renal lithium elimination by 23% and causing a 40% increase in steady-state plasma lithium levels 3.
Recent research confirms that NSAIDs independently increase lithium levels in routine clinical practice, with NSAIDs identified as the only drug class among potentially interacting medications to independently elevate lithium concentrations 4.
Critical Clinical Considerations
If NSAIDs Must Be Used:
The FDA label provides clear guidance: "Lithium levels should be closely monitored when patients initiate or discontinue NSAID use" 1. Specifically:
- Check serum lithium levels every 4-5 days until the extent of drug interaction is assessed 5
- Lithium dosage may need to be decreased 1
- Ensure patients are well-hydrated 6
- Monitor renal function before treatment initiation 6
Safer Alternatives:
Aspirin (particularly low-dose) appears safer than other NSAIDs. Studies show aspirin does not significantly affect steady-state plasma lithium levels and may even have beneficial effects in bipolar disorder 3, 7. One study found low-dose aspirin significantly reduced clinical deterioration in lithium-treated patients 7.
Acetaminophen is the preferred analgesic for patients on lithium, as it does not affect lithium levels and avoids the renal prostaglandin-mediated interaction 8.
Common Pitfalls to Avoid
Over-the-counter NSAIDs: Patients often self-medicate with ibuprofen or naproxen without informing clinicians. Explicitly warn patients about this risk 4.
COX-2 inhibitors are not safer: Despite theoretical advantages, celecoxib and rofecoxib both increase lithium levels significantly 2, 1.
"Low-dose" lithium is not protective: The interaction is pharmacokinetic (affecting lithium clearance), not dose-dependent. Even therapeutic lithium levels can become toxic with NSAID co-administration.
Sulindac uncertainty: While some older literature suggested sulindac might be safer 5, the evidence is inconsistent and this should not be relied upon clinically.
The Bottom Line Algorithm
For patients on lithium requiring analgesia:
- First choice: Acetaminophen (up to 3-4g/day, monitoring liver function)
- Second choice: Low-dose aspirin (if anti-inflammatory effect needed)
- If NSAIDs unavoidable:
- Check baseline lithium level
- Start NSAID at lowest effective dose
- Recheck lithium level every 4-5 days
- Consider empiric 25-50% lithium dose reduction
- Ensure adequate hydration
- Monitor for lithium toxicity symptoms (tremor, confusion, ataxia, GI symptoms)
The guideline consensus is clear: NSAIDs pose a clinically significant risk of lithium toxicity through reduced renal clearance, and this risk exists regardless of lithium dose 6, 9, 1.